EP4701439A1 - Zusammensetzungen und verfahren zur verbesserung der gehirngesundheit - Google Patents

Zusammensetzungen und verfahren zur verbesserung der gehirngesundheit

Info

Publication number
EP4701439A1
EP4701439A1 EP24723490.9A EP24723490A EP4701439A1 EP 4701439 A1 EP4701439 A1 EP 4701439A1 EP 24723490 A EP24723490 A EP 24723490A EP 4701439 A1 EP4701439 A1 EP 4701439A1
Authority
EP
European Patent Office
Prior art keywords
composition
weight
individual
lactose
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP24723490.9A
Other languages
English (en)
French (fr)
Inventor
Stefan Christen
Jean-Philippe Godin
Olga SAKWINSKA
Maria Pilar GINER
Léa SIEGWALD
Marcus BOEHME
Claire Laurence Lucie Marie BOULANGE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Publication of EP4701439A1 publication Critical patent/EP4701439A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Psychiatry (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP24723490.9A 2023-04-28 2024-04-29 Zusammensetzungen und verfahren zur verbesserung der gehirngesundheit Pending EP4701439A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202363462788P 2023-04-28 2023-04-28
US202363522802P 2023-06-23 2023-06-23
PCT/EP2024/061788 WO2024223938A1 (en) 2023-04-28 2024-04-29 Compositions and methods for improving brain health

Publications (1)

Publication Number Publication Date
EP4701439A1 true EP4701439A1 (de) 2026-03-04

Family

ID=90971405

Family Applications (1)

Application Number Title Priority Date Filing Date
EP24723490.9A Pending EP4701439A1 (de) 2023-04-28 2024-04-29 Zusammensetzungen und verfahren zur verbesserung der gehirngesundheit

Country Status (6)

Country Link
EP (1) EP4701439A1 (de)
CN (1) CN121099915A (de)
AU (1) AU2024260161A1 (de)
CL (1) CL2025003315A1 (de)
MX (1) MX2025012854A (de)
WO (1) WO2024223938A1 (de)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2656776T3 (es) 2008-06-13 2018-02-28 N.V. Nutricia Composición nutricional para bebés nacidos por cesárea
EP2526784A1 (de) 2011-05-24 2012-11-28 Nestec S.A. Milcholigosaccharid-Galactooligosaccharid-Zusammensetzung für Kindernahrung mit niedrigem Monosaccharidgehalt, enthaltend die in der Milch vorhandene lösliche Oligosaccharidfraktion, sowie ein Verfahren zur Herstellung der Zusammensetzung
GB2492559B (en) * 2011-07-05 2018-07-25 Clasado Inc Composition and method for preventing or reducing the risk of developing a syndrome
HK1202244A1 (en) * 2011-11-30 2015-09-25 里特制药股份有限公司 Prebiotic formulations and methods of use
GB201305708D0 (en) * 2013-03-28 2013-05-15 Clasado Inc Novel use
CN107106584A (zh) 2014-12-08 2017-08-29 格礼卡姆股份公司 用于治疗代谢障碍的合成组合物
AU2018269327B2 (en) 2017-05-15 2024-04-04 Kerry Group Services International Ltd Milk products comprising high amounts of galactooligosaccharides (GOS) and their production
CN108210504A (zh) * 2017-12-27 2018-06-29 中国科学院海洋研究所 硫酸化半乳寡糖的应用及药物组合物
US20240309408A1 (en) 2021-05-13 2024-09-19 Bcd Bioscience, Inc. Methods of Use of Oligosaccharide Compositions for Modulating Microbiota and their Metabolic Products, and as Therapeutics for Health Applications
WO2023057540A1 (en) 2021-10-07 2023-04-13 Société des Produits Nestlé S.A. Process for preparing enzymatically-treated food compositions with gos and low lactose content and food compositions thereof

Also Published As

Publication number Publication date
AU2024260161A1 (en) 2025-10-16
WO2024223938A1 (en) 2024-10-31
CL2025003315A1 (es) 2025-12-05
MX2025012854A (es) 2025-12-01
CN121099915A (zh) 2025-12-09

Similar Documents

Publication Publication Date Title
EP2708145B1 (de) Nahrungsmitteln zur Verwendung zur Modulation von Corticosteronspiegeln bei psychisch belasteten Menschen
EP3035949B1 (de) Aus zuckerrohr gewonnene extrakte und verwendungen
JP2009502958A (ja) ストレスの治療または管理の方法
Shi et al. The effects of supplementation with blueberry, cyanidin-3-O-β-glucoside, yoghurt and its peptides on obesity and related comorbidities in a diet-induced obese mouse model
CN103998051A (zh) 桑属浆果及其避免血糖峰值的用途
EP2011500A1 (de) Fettakkumulationshemmer
CN104095894A (zh) 包含人参果实提取物的脑激活组合物
CN111466439A (zh) 具有血糖值上升抑制作用的发酵乳
CN102014893A (zh) 用于治疗软骨障碍的多酚类
JP2012527224A (ja) オピオイド受容体刺激化合物（チモキノン、ニゲラ・サティバ）及び食物アレルギー
RU2491083C2 (ru) Применение фитоэкдизонов и получение композиции для воздействия на метаболический синдром
CN107106618B (zh) 鞘脂吸收促进剂
WO2005041995A1 (ja) α-グルコシダーゼ活性阻害剤
CN107073032B (zh) 肾衰竭发展抑制剂、肾衰竭预防剂及硫酸吲哚酚产生抑制剂
AU2024260161A1 (en) Compositions and methods for improving brain health
AU2024260462A1 (en) Compositions and methods for improving metabolic health
WO2024223939A1 (en) Compositions and methods for improving immune health
WO2020029221A1 (zh) 具有抑制脂肪形成及抗氧化活性的组合物及其用途
US20120100222A1 (en) Skin function-improving composition
CN115990200A (zh) 一种生物营养补充剂及其应用
WO2026052695A1 (en) Compositions and methods for improving gastrointestinal health
US20250017973A1 (en) Nutritional composition for cancer
TW202034944A (zh) 一種大豆分離蛋白用於製備預防或治療骨鬆合併肌少症、提升身體機能及降低運動後疲勞之組合物的用途。
WO2026052725A1 (en) Food ingredient and beverage products
KR20260008799A (ko) 유지방 구막을 포함하는 유제품 및 이의 제조방법

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20251128

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR